About Meng Deng
Form D filings for Adipo Therapeutics from 2020 to 2024 list Meng Deng as director.
Meng Deng first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Meng Deng in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Meng Deng works with at each company, as listed on that company's latest Form D.
Adipo Therapeutics, LLC · Form D, Dec 11, 2024